Can I stop taking Ixazomib/Enleri for almost 2 years?

Before deciding whether to discontinue ixazomib/Ixazomib, patients need to consider multiple factors. First, ixazomib is an oral proteasome inhibitor commonly used to treat multiple myeloma, often in combination with other drugs. For patients who have been taking it for nearly two years, its efficacy and tolerability first need to be evaluated. If the patient's condition is under control during this period and no significant side effects occur, continued medication may be appropriate.

Doctors will determine whether the medication can be safely discontinued based on the patient's specific condition, laboratory test results, and imaging studies. In some cases, your doctor may recommend tapering the medication gradually rather than stopping it suddenly to see how your body responds. At the same time, considering that multiple myeloma may have a risk of recurrence, doctors may develop a personalized discontinuation plan based on the patient's disease course.

The patient's overall health also needs to be considered when evaluating discontinuation. If the patient has other underlying diseases or health problems, stopping the drug may cause the patient's condition to fluctuate. In addition, the patient's tolerance to the drug is also very important. Some patients may experience more serious side effects, and discontinuation of the drug may be due to considerations of improving quality of life.

In addition, regular follow-up and monitoring are also critical. If the patient decides to stop taking the drug, the patient needs to agree with the doctor on a regular review time to detect any abnormalities in time, such as recurrence of the condition. At the same time, doctors may advise patients to maintain good living habits after stopping medication, including a balanced diet, moderate exercise and mental health management, which can help improve the body's immunity and resistance.

Whether continuing to take medication or discontinuing medication, patients need to actively participate in their own treatment decisions and fully communicate with the medical team. Patients' opinions and feelings greatly influence the effectiveness of treatment and quality of life.